Mao-Draayer Y - Search Results

1

Siponimod enriches regulatory T and B lymphocytes in secondary progressive multiple sclerosis.

Wu Q, Mills EA, Wang Q, Dowling CA, Fisher C, Kirch B, Lundy SK, Fox DA, Mao-Draayer Y; AMS04 Study Group. Wu Q, et al. JCI Insight. 2020 Feb 13;5(3):e134251. doi: 10.1172/jci.insight.134251. JCI Insight. 2020. PMID: 31935197 Free PMC article.

2

Dimethyl Fumarate Protects Neural Stem/Progenitor Cells and Neurons from Oxidative Damage through Nrf2-ERK1/2 MAPK Pathway.

Wang Q, Chuikov S, Taitano S, Wu Q, Rastogi A, Tuck SJ, Corey JM, Lundy SK, Mao-Draayer Y. Wang Q, et al. Int J Mol Sci. 2015 Jun 17;16(6):13885-907. doi: 10.3390/ijms160613885. Int J Mol Sci. 2015. PMID: 26090715 Free PMC article.

3

Interferon beta (IFN-β) treatment exerts potential neuroprotective effects through neurotrophic factors and novel neurotensin/neurotensin high affinity receptor 1 pathway.

Wang Q, Mao-Draayer Y. Wang Q, et al. Neural Regen Res. 2015 Dec;10(12):1932-3. doi: 10.4103/1673-5374.169636. Neural Regen Res. 2015. PMID: 26889174 Free PMC article. No abstract available.

4

Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets.

Lundy SK, Wu Q, Wang Q, Dowling CA, Taitano SH, Mao G, Mao-Draayer Y. Lundy SK, et al. Neurol Neuroimmunol Neuroinflamm. 2016 Mar 3;3(2):e211. doi: 10.1212/NXI.0000000000000211. eCollection 2016 Apr. Neurol Neuroimmunol Neuroinflamm. 2016. PMID: 27006972 Free PMC article.

5

The sphingosine-1-phosphate receptor: A novel therapeutic target for multiple sclerosis and other autoimmune diseases.

Mao-Draayer Y, Sarazin J, Fox D, Schiopu E. Mao-Draayer Y, et al. Clin Immunol. 2017 Feb;175:10-15. doi: 10.1016/j.clim.2016.11.008. Epub 2016 Nov 23. Clin Immunol. 2017. PMID: 27890706 Free PMC article. Review.

6

Dimethyl Fumarate Selectively Reduces Memory T Cells and Shifts the Balance between Th1/Th17 and Th2 in Multiple Sclerosis Patients.

Wu Q, Wang Q, Mao G, Dowling CA, Lundy SK, Mao-Draayer Y. Wu Q, et al. J Immunol. 2017 Apr 15;198(8):3069-3080. doi: 10.4049/jimmunol.1601532. Epub 2017 Mar 3. J Immunol. 2017. PMID: 28258191 Free PMC article.

7

Emerging Approaches for Validating and Managing Multiple Sclerosis Relapse.

Mills EA, Mirza A, Mao-Draayer Y. Mills EA, et al. Front Neurol. 2017 Mar 29;8:116. doi: 10.3389/fneur.2017.00116. eCollection 2017. Front Neurol. 2017. PMID: 28424654 Free PMC article. Review.

8

Hemicholinium-3 sensitive choline transport in human T lymphocytes: Evidence for use as a proxy for brain choline transporter (CHT) capacity.

Koshy Cherian A, Parikh V, Wu Q, Mao-Draayer Y, Wang Q, Blakely RD, Sarter M. Koshy Cherian A, et al. Neurochem Int. 2017 Sep;108:410-416. doi: 10.1016/j.neuint.2017.05.022. Epub 2017 May 31. Neurochem Int. 2017. PMID: 28577989 Free PMC article.

9

Optical coherence tomography and T cell gene expression analysis in patients with benign multiple sclerosis.

Soltys J, Wang Q, Mao-Draayer Y. Soltys J, et al. Neural Regen Res. 2017 Aug;12(8):1352-1356. doi: 10.4103/1673-5374.213558. Neural Regen Res. 2017. PMID: 28966652 Free PMC article.

10

Pathologic Findings of Chronic PML-IRIS in a Patient with Prolonged PML Survival Following Natalizumab Treatment.

Himedan M, Camelo-Piragua S, Mills EA, Gupta A, Aburashed R, Mao-Draayer Y. Himedan M, et al. J Investig Med High Impact Case Rep. 2017 Sep 27;5(3):2324709617734248. doi: 10.1177/2324709617734248. eCollection 2017 Jul-Sep. J Investig Med High Impact Case Rep. 2017. PMID: 28989935 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

81 results

Search Page

Filters